DRGem

DRGem FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of DRGem (263690.KQ) as of Oct 20, 2026 is 106.44 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 0.54 % — a change of 19,651.26% (higher).

FCF Conversion

106.44 %

YoY

19,651.26%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of DRGem is 2025 106.44 % . FCF Conversion Rate (FCF/EBITDA) of DRGem was 2024 0.54 % . It decreases by 19,651.26% higher compared to the previous year.

The DRGem FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
59.33 KRW
Jan 1, 2019
21.64 KRW
Jan 1, 2020
48.26 KRW
Jan 1, 2021
71.38 KRW
Jan 1, 2022
-56.47 KRW
Jan 1, 2023
29.47 KRW
Jan 1, 2024
0.54 KRW
Jan 1, 2025
106.44 KRW
The DRGem FCF Conversion history
YEARFCF ConversionYoY
106.44 %+19,651.26%
0.54 %-98.17%
29.47 %-152.19%
-56.47 %-179.12%
71.38 %+47.90%
48.26 %+122.99%
21.64 %-63.52%
59.33 %-243.60%
-41.32 %-103.40%
1,215.99 %+6,106.05%
19.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DRGem Stock analysis

What does DRGem do? DRGEM Corp. generates revenue through the manufacturing and sale of diagnostic X-ray systems, including analog, digital, and retrofit models, as well as high voltage X-ray generators and mobile X-ray systems. The company serves domestic and international markets with its product portfolio, which features veterinary digital radiography systems and digital upgrade systems. Key customers include healthcare facilities requiring medical imaging solutions, while the firm focuses on both established diagnostic equipment and modern digital upgrades for existing systems. The firm's product range spans diagnostic analog X-ray systems, diagnostic digital X-ray systems, and diagnostic retrofit X-ray systems, alongside components like high voltage X-ray generators. These products are distributed domestically and internationally, targeting hospitals, clinics, and veterinary practices seeking advanced imaging technology. DRGEM Corp. emphasizes digital transformation in radiography, offering systems that modernize legacy equipment through retrofit solutions. DRGEM Corp. monetizes its expertise in X-ray technology by providing comprehensive solutions for medical and veterinary sectors. Its diagnostic digital X-ray systems and mobile X-ray systems cater to evolving healthcare demands, while digital upgrade systems enable cost-effective modernization of older equipment. The company's revenue streams are driven by direct sales of these specialized products to healthcare providers and veterinary institutions across multiple regions. DRGem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DRGem stock

FCF Conversion Rate (FCF/EBITDA) of DRGem is 106.44 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of DRGem changed from 0.54 % to 106.44 %, representing a 19,651.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) DRGem since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s DRGem with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DRGem

All Key Metrics — DRGem